Search

Search Constraints

You searched for: Author/Creator Lebensburger, Jeffrey D.

Search Results

1. 13‐valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6‐17 years of age with sickle cell disease previously vaccinated with 23‐valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study. Issue 8 (23rd March 2015)

2. 13‐valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6‐17 years of age with sickle cell disease previously vaccinated with 23‐valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study. Issue 8 (23rd March 2015)

3. Consensus definition of essential, optimal, and suggested components of a pediatric sickle cell disease center. Issue 1 (12th September 2022)